Shabman Reed S, Morrison Thomas E, Moore Christopher, White Laura, Suthar Mehul S, Hueston Linda, Rulli Nestor, Lidbury Brett, Ting Jenny P-Y, Mahalingam Suresh, Heise Mark T
Department of Genetics, The Carolina Vaccine Institute, The University of North Carolina, Chapel Hill, NC 27599, USA.
J Virol. 2007 Jan;81(1):237-47. doi: 10.1128/JVI.01590-06. Epub 2006 Nov 1.
Dendritic cells (DCs) are an important early target cell for many mosquito-borne viruses, and in many cases mosquito-cell-derived arboviruses more efficiently infect DCs than viruses derived from mammalian cells. However, whether mosquito-cell-derived viruses differ from mammalian-cell-derived viruses in their ability to induce antiviral responses in the infected dendritic cell has not been evaluated. In this report, alphaviruses, which are mosquito-borne viruses that cause diseases ranging from encephalitis to arthritis, were used to determine whether viruses grown in mosquito cells differed from mammalian-cell-derived viruses in their ability to induce type I interferon (IFN) responses in infected primary dendritic cells. Consistent with previous results, mosquito-cell-derived Ross River virus (mos-RRV) and Venezuelan equine encephalitis virus (mos-VEE) exhibited enhanced infection of primary myeloid dendritic cells (mDCs) compared to mammalian-cell-derived virus preparations. However, unlike the mammalian-cell-derived viruses, which induced high levels of type I IFN in the infected mDC cultures, mos-RRV and mos-VEE were poor IFN inducers. Furthermore, the poor IFN induction by mos-RRV contributed to the enhanced infection of mDCs by mos-RRV. These results suggest that the viruses initially delivered by the mosquito vector differ from those generated in subsequent rounds of replication in the host, not just with respect to their ability to infect dendritic cells but also in their ability to induce or inhibit antiviral type I IFN responses. This difference may have an important impact on the mosquito-borne virus's ability to successfully make the transition from the arthropod vector to the vertebrate host.
树突状细胞(DCs)是许多蚊媒病毒重要的早期靶细胞,在很多情况下,源自蚊细胞的虫媒病毒比源自哺乳动物细胞的病毒更有效地感染DCs。然而,源自蚊细胞的病毒与源自哺乳动物细胞的病毒在诱导被感染树突状细胞产生抗病毒反应的能力方面是否存在差异尚未得到评估。在本报告中,我们使用了α病毒(一种蚊媒病毒,可引发从脑炎到关节炎等多种疾病)来确定在蚊细胞中培养的病毒与源自哺乳动物细胞的病毒在诱导被感染的原代树突状细胞产生I型干扰素(IFN)反应的能力方面是否存在差异。与先前的结果一致,与源自哺乳动物细胞的病毒制剂相比,源自蚊细胞的罗斯河病毒(mos-RRV)和委内瑞拉马脑炎病毒(mos-VEE)对原代髓样树突状细胞(mDCs)的感染能力增强。然而,与在被感染的mDC培养物中诱导高水平I型干扰素的源自哺乳动物细胞的病毒不同,mos-RRV和mos-VEE是较弱的干扰素诱导剂。此外,mos-RRV诱导干扰素能力较弱导致了mos-RRV对mDCs的感染能力增强。这些结果表明,最初由蚊媒传播的病毒与在宿主后续复制轮次中产生的病毒不同,不仅在感染树突状细胞的能力方面存在差异,而且在诱导或抑制抗病毒I型干扰素反应的能力方面也存在差异。这种差异可能对蚊媒病毒成功从节肢动物载体向脊椎动物宿主转变的能力产生重要影响。